PRAKASH MASAND to Follow-Up Studies
This is a "connection" page, showing publications PRAKASH MASAND has written about Follow-Up Studies.
Connection Strength
0.142
-
Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: analyses of ziprasidone clinical study data. Schizophr Res. 2011 Mar; 126(1-3):174-83.
Score: 0.048
-
Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study. J Cyst Fibros. 2023 03; 22(2):248-255.
Score: 0.027
-
Early evidence of pulmonary dysfunction in survivors of childhood Hodgkin lymphoma. Leuk Lymphoma. 2020 10; 61(10):2419-2427.
Score: 0.023
-
Vascular invasion is a prognostic indicator in hepatoblastoma. J Pediatr Surg. 2017 Jun; 52(6):956-961.
Score: 0.019
-
Relapsed hepatoblastoma confined to the lung is effectively treated with pulmonary metastasectomy. J Pediatr Surg. 2016 Apr; 51(4):525-9.
Score: 0.017
-
Clinical variables associated with early administration of antipsychotics in bipolar mania. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan; 30(1):151-4.
Score: 0.008